MPM Oncology Impact Management GP LLC, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 25,942 shares at $20.04 ($520K) on 2021-05-14, disclosed to the SEC on 2021-05-17.
Open-market sale of $520k HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.06 | 4,855 | $97K | 18.7% |
| 2 | $20.06 | 4,855 | $97K | 18.7% |
| 3 | $20.04 | 6,900 | $138K | 26.6% |
| 4 | $20.07 | 4,666 | $94K | 18.0% |
| 5 | $20.07 | 4,666 | $94K | 18.0% |
| Total | $20.06 avg | 25,942 |
| $520K |
| 100% |
| Filing → |
| HARP | SELL | 2021-05-20 | $2.0M | — | Filing → |
| HARP | SELL | 2021-05-04 | $14.7M | — | Filing → |
| HARP | SELL | 2021-04-22 | $330K | — | Filing → |